MedPath

A multicentre pre-randomised clinical study of Xiao'er Jiangqi Pingxiao Heji in the treatment of asthma exacerbations in childre

Early Phase 1
Conditions
asthma
Registration Number
ITMCTR2023000053
Lead Sponsor
anjing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Anyone who meets the diagnostic criteria of western medicine and the syndrome criteria of external cold and internal heat syndrome of traditional Chinese medicine;
2. Age between 3 and 12 years old, regardless of gender;
3. Acute onset, according to the judgment standard, the condition is mild or moderate;
4. No treatment has been given in the past 3 days after the onset.

Exclusion Criteria

1. Stable condition or in asthma remission;
2. Severe asthma, status asthmaticus, critically ill patients, and patients with pulmonary infection;
3. Those who are accompanied by other diseases that cause asthma or dyspnea in patients and affect the evaluation of curative effect;
4. Patients with primary diseases such as cardiovascular and cerebrovascular, liver and kidney, and hematopoietic system;
5. Those who are allergic to the ingredients of this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chinese Medicine Evidence Score;Time for clinical symptoms to disappear;
Secondary Outcome Measures
NameTimeMethod
FeNO;Exhaled breath condensate detection;Blood Eosinophil Count;Lung function indicators;
© Copyright 2025. All Rights Reserved by MedPath